Cardiol Therapeutics Overview

  • Founded
  • 2017
  • Status
  • Public
  • Employees
  • 14
  • Stock Symbol
  • CRDL
Stock Symbol
  • Share Price
  • $2.16
  • (As of Friday Closing)

Cardiol Therapeutics General Information


Cardiol Therapeutics Inc is a clinical-stage biotechnology company developing therapies for inflammatory heart disease. The company has received approval to commence a Phase II/III clinical trial investigating its product, CardiolRx, in COVID-19 patients with history of cardiovascular disease. CardiolRx is a pharmaceutically produced, GMP certified, THC free (<10 ppm) oral cannabidiol formulation.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 2265 Upper Middle Road East
  • Suite 602
  • Oakville, Ontario L6H 0G5
  • Canada
+1 (289) 000-0000

Cardiol Therapeutics Timeline

Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiol Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.16 $2.20 $1.48 - $4.19 $92.4M 42.7M 184K -$0.63

Cardiol Therapeutics Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 103,666 59,297 83,249 74,907
Revenue 0 0 0 0
EBITDA (19,985) (15,268) (10,380) (11,757)
Net Income (20,101) (15,382) (10,309) (12,259)
Total Assets 16,714 12,464 11,868 18,124
Total Debt 117 123 146 198
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardiol Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cardiol Therapeutics‘s full profile, request access.

Request a free trial

Cardiol Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
David Elsley Chief Executive Officer & Board Member
Chris Waddick Chief Financial Officer
Bernard Lim Chief Operating Officer, Operations
Anthony Bolton Co-Founder & Director of Research
Thomas Moffatt Executive
You’re viewing 5 of 7 executive team members. Get the full list »

Cardiol Therapeutics Board Members (9)

Name Representing Role Since
Colin Stott Cardiol Therapeutics Board Member 000 0000
David Elsley Cardiol Therapeutics Chief Executive Officer & Board Member 000 0000
Deborah Brown Cardiol Therapeutics Board Member 000 0000
Eldon Smith MD Cardiol Therapeutics Co-Founder & Chairman 000 0000
Guillermo Torre-Amione MD Cardiol Therapeutics Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Cardiol Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial